June 21, 2022

Novel Therapies for NSCLC With EGFR Exon 20 Insertions: Practical Pearls for the Clinic

Listen Later

41 minutes

Are you aware that there are now targeted therapies available for patients harboring exon 20 insertions, the third most common type of EGFR mutation in non-small cell lung cancer (NSCLC)?

Credit available for this activity expires: 6/20/2023

Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/975726?src=mkm_podcast_addon_975726

...more

View all episodes

View all episodes

Download on the App Store

Download on the App Store

Get it on Google Play

Keeping Current

By Medscape Podcasts

4

77 ratings

June 21, 2022

Novel Therapies for NSCLC With EGFR Exon 20 Insertions: Practical Pearls for the Clinic

Listen Later

41 minutes

Are you aware that there are now targeted therapies available for patients harboring exon 20 insertions, the third most common type of EGFR mutation in non-small cell lung cancer (NSCLC)?

Credit available for this activity expires: 6/20/2023

Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/975726?src=mkm_podcast_addon_975726

...more